Home/Filings/4/0001209191-23-054577
4//SEC Filing

Leheny A. Rachel 4

Accession 0001209191-23-054577

CIK 0001534133other

Filed

Nov 5, 7:00 PM ET

Accepted

Nov 6, 6:39 PM ET

Size

8.4 KB

Accession

0001209191-23-054577

Insider Transaction Report

Form 4
Period: 2023-11-03
Leheny A. Rachel
DirectorCHIEF EXECUTIVE OFFICER10% Owner
Transactions
  • Purchase

    Common Stock

    2023-11-03$2.85/sh+5,000$14,25014,400 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    1,000
  • Common Stock

    (indirect: By LLC)
    316,109
  • Common Stock

    (indirect: By LLC)
    356,989
  • Common Stock

    (indirect: By LLC)
    66,228
Footnotes (1)
  • [F1]The Reporting Person, a co-founder and managing director of Valence Investments SPV IV, LLC ("Valence IV"), Valence Investments SPV V, LLC ("Valence V") and Valence Investments SPV VI, LLC (Valence VI), may be deemed to beneficially own the securities held by Valence IV, Valence V and Valence VI (the "Valence Securities"). The Reporting Person disclaims beneficial ownership of the Valence Securities except to the extent of her pecuniary interest therein.

Issuer

CalciMedica, Inc.

CIK 0001534133

Entity typeother

Related Parties

1
  • filerCIK 0001484729

Filing Metadata

Form type
4
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 6:39 PM ET
Size
8.4 KB